ARTICLE | Company News
Replidyne submits Orapem NDA
January 10, 2006 4:55 AM UTC
Replidyne (Louisville, Colo.) submitted an NDA to FDA for Orapem faropenem for acute bacterial sinusitis, community acquired pneumonia (CAP), acute exacerbations of chronic bronchitis and uncomplicate...